Company Overview of Astellas Pharma, Inc.
Sef P. Kurstjens M.D., Ph.D.
Chief Medical Officer and President of Global Development, Astellas Pharma, Inc.
|Age||Total Calculated Compensation||This person is connected to 1 Board Members in 1 different organizations across 3 different industries.|
See Board Relationships
2-5-1, Nihonbashi-HonchoPhone: 81 3 3244 3000
Tokyo, -- 103-8411
Board Members Memberships
Wits Medical School
Annual CompensationThere is no Annual Compensation data available.
Stocks OptionsThere is no Stock Options data available.
Total CompensationThere is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|Vincent A. Forlenza||Chairman, Chief Executive Officer, President and Chairman of Executive Committee|
Becton, Dickinson and Company
|José E. Almeida||Chairman and Chief Executive Officer|
Baxter International Inc.
|Joseph C. Papa||Chairman of the Board and Chief Executive Officer|
Valeant Pharmaceuticals International, Inc.
|Jean-Pierre Clamadieu||Chief Executive Officer, Director and Member of Finance Committee|
|Paul R. Perreault BA Psychology||Chief Executive Officer, Managing Director, Executive Director and Member of Securities & Market Disclosure Committee|
|$5.0M||Compensation as of Fiscal Year 2015.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.